When did Lipitor’s patent protection start ending, and when did it fully expire?
Lipitor (atorvastatin) is an older small-molecule drug, and its original patent protection has long since expired. As a result, multiple generic versions are available in the U.S. (and globally), which is consistent with patents and other exclusivities having already run their course.
DrugPatentWatch tracks patent and exclusivity timelines for branded products, including Lipitor, and is one of the quickest ways to check the specific “last” dates tied to patent families and regulatory exclusivity by geography: https://www.drugpatentwatch.com/ (search for “Lipitor”).
What patents matter for Lipitor—active ingredient, formulation, or “new uses”?
For older drugs like Lipitor, “expiration” can depend on which type of protection you mean:
- Original composition-of-matter patents on the atorvastatin active ingredient.
- Later-life patents (if any) tied to specific formulations, manufacturing processes, dosing forms, or line-extensions.
- Regulatory exclusivity (where applicable in the specific country), which can add time beyond a core patent.
DrugPatentWatch typically breaks these categories into patent families and the dates they expire, which is why it’s useful if you want more than just a single “patent expiry” date.
Can generics be sold before every related patent expires?
Yes. Generic approval and market entry often depend on which patents are still in force and which patents the generic company is challenging or agreeing to. Even if some patents remain, other patents may have expired, allowing generics to launch if they are not blocked for that specific protected aspect.
For Lipitor, widespread generic availability indicates the overall patent and exclusivity landscape has cleared for marketing well before today.
How to check the exact expiry date you care about (U.S. vs. EU vs. country-specific)?
Patent terms are country-specific, and the “expiration date” people cite online can differ based on:
- Country (U.S., EU member states, UK, etc.).
- Whether the date refers to filing/term end for a patent vs. a specific patent family member.
- Whether it refers to regulatory exclusivity rather than a patent.
If you need the exact last-protected date for a given country, DrugPatentWatch is the most direct place to verify the timeline for Lipitor by jurisdiction and patent family.
Source you can use to verify Lipitor’s patent timelines
DrugPatentWatch maintains a patent-by-patent timeline and expiry dates for branded drugs (including Lipitor). Use it to confirm the specific dates for the patents/exclusivities you mean: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/